Home LiteratureArticle Details
PMID: 17347379 Published · ppublish English Comparative Study Evaluation Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches.

Journal of applied physiology (Bethesda, Md. : 1985) ·Vol. 102 ·No. 6 ·2007-06-00 ·Pages 2104-11

Takagawa J, Zhang Y, Wong ML, Sievers RE, Kapasi NK, Wang Y, Yeghiazarians Y, Lee RJ, Grossman W, Springer ML

Abstract

Efficacy of potential treatments for myocardial infarction (MI) is commonly assessed by histological measurement of infarct size in rodent models. In experiments involving an acute MI setting, measurement of the infarcted area in tissue sections of the left ventricle is a standard approach to determine infarct size. This approach has also been used in the chronic infarct setting to measure infarct area several weeks post-MI. We tested the hypothesis that, because wall thinning is known to occur in the chronic setting, the area measurement approach would be less appropriate. We compared infarct measurements in tissue sections based on 1) infarct area, 2) epicardial and endocardial infarct arc lengths, and 3) midline infarct arc length. Infarct sizes from all three measurement approaches correlated significantly with left ventricular ejection fraction and wall motion abnormality. However, the infarct size values derived from the area measurement approach were significantly smaller than those from the other two measurement approaches, and the range of values obtained was compressed 0.4-fold. The midline method allowed detection of the expected size differences between infarcts of variable severity resulting from proximal vs. distal ligation of the coronary artery. Segmental infarct size was correlated with segmental wall motion abnormality. We conclude that both area- and length-based measurements can be used to determine relative infarct size over a wide range of severity, although the area-based measurements are substantially more compressed due to wall thinning, and that the estimation of infarct midlines is a simple, reliable approach to infarct size assessment.

MeSH Terms
Anatomy, Cross-Sectional/methods Animals Chronic Disease Disease Models, Animal Humans Image Interpretation, Computer-Assisted/methods Male Mice Mice, Inbred C57BL Myocardial Infarction/diagnostic imaging,pathology Reproducibility of Results Sensitivity and Specificity Ultrasonography
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Takagawa Junya
Department of Medicine, Division of Cardiology, University of California, San Francisco, 513 Parnassus Ave., Rm. S1136, Box 0124, San Francisco, CA 94143-0124, USA.
Zhang Yan
Wong Maelene L
Sievers Richard E
Kapasi Neel K
Wang Yan
Yeghiazarians Yerem
Lee Randall J
Grossman William
Springer Matthew L
References (26)
26 references, click to expand
  1. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart.
    J Mol Cell Cardiol. 2003 Sep;35(9):1113-9 PMID: 12967634
  2. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair.
    Am J Pathol. 2003 Dec;163(6):2433-40 PMID: 14633615
  3. Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling.
    Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15883-8 PMID: 14665690
  4. Validation of the wall motion score and myocardial performance indexes as novel techniques to assess cardiac function in mice after myocardial infarction.
    Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H1187-92 PMID: 17028161
  5. Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer.
    Biomaterials. 2005 Apr;26(10):1139-44 PMID: 15451633
  6. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?
    Circulation. 2004 Oct 12;110(15):2175-9 PMID: 15466649
  7. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution.
    Am J Pathol. 1978 Jan;90(1):57-70 PMID: 619696
  8. Myocardial infarct size and ventricular function in rats.
    Circ Res. 1979 Apr;44(4):503-12 PMID: 428047
  9. Progressive ventricular remodeling in rat with myocardial infarction.
    Am J Physiol. 1991 May;260(5 Pt 2):H1406-14 PMID: 2035662
  10. Ischemic preconditioning decreases apoptosis in rat hearts in vivo.
    Circulation. 1997 Sep 2;96(5):1598-604 PMID: 9315553
  11. Ventricular remodeling in a mouse model of myocardial infarction.
    Am J Physiol. 1998 May;274(5 Pt 2):H1812-20 PMID: 9612394
  12. Chronic myocardial infarction in the mouse: cardiac structural and functional changes.
    Cardiovasc Res. 1999 Mar;41(3):586-93 PMID: 10435030
  13. Myocardial infarction and remodeling in mice: effect of reperfusion.
    Am J Physiol. 1999 Aug;277(2 Pt 2):H660-8 PMID: 10444492
  14. Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts.
    Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16280-5 PMID: 15534198
  15. Quantitative assessment of infarct size in vivo by myocardial contrast echocardiography in a murine acute myocardial infarction model.
    Int J Cardiol. 2004 Dec;97(3):393-8 PMID: 15561324
  16. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects.
    Circulation. 2005 Jul 12;112(2):214-23 PMID: 15998673
  17. Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography.
    Am J Physiol Heart Circ Physiol. 2005 Sep;289(3):H1307-14 PMID: 15908468
  18. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen.
    J Mol Cell Cardiol. 2005 Sep;39(3):521-9 PMID: 15950985
  19. Competitive displacement of phosphoinositide 3-kinase from beta-adrenergic receptor kinase-1 improves postinfarction adverse myocardial remodeling.
    Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1754-60 PMID: 16699071
  20. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts.
    Nat Med. 2003 Sep;9(9):1195-201 PMID: 12910262
  21. Echocardiographic evaluation of ventricular remodeling in a mouse model of myocardial infarction.
    J Am Soc Echocardiogr. 2002 Jun;15(6):601-9 PMID: 12050601
  22. Mobilized bone marrow cells repair the infarcted heart, improving function and survival.
    Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10344-9 PMID: 11504914
  23. Bone marrow cells regenerate infarcted myocardium.
    Nature. 2001 Apr 5;410(6829):701-5 PMID: 11287958
  24. Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice.
    Cardiovasc Res. 2000 Jan 14;45(2):330-8 PMID: 10728353
  25. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion.
    J Am Coll Cardiol. 2000 Mar 1;35(3):787-95 PMID: 10716484
  26. Induction of myocardial infarcts of a predictable size and location by branch pattern probability-assisted coronary ligation in C57BL/6 mice.
    Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H1201-7 PMID: 14766681
Article Info
Journal
Journal of applied physiology (Bethesda, Md. : 1985)
Abbr.
J Appl Physiol (1985)
ISSN
8750-7587
Published
2007-06-00
Epub
2007-00-08
Pages
2104-11
Language
English
Region
United States
NLM ID
8502536
PMCID
PMC2675697
Subset
IM
Grants
NIBIB NIH HHS · R03 EB005802 · United States
NIBIB NIH HHS · R03 EB005802-01 · United States
NIBIB NIH HHS · R03 EB005802-02 · United States
NIBIB NIH HHS · 1 R03 EB-005802 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]